Pharmacological evaluation of Adenostemma lavenia acetone extract in Swiss Albino mice: Analgesic, anti‐inflammatory, and thrombolytic insights from in vivo, in vitro, density functional theory, and molecular docking studies
Animal Models and Experimental Medicine · 2026-04 · 9 (4) · 765-784
DOI: 10.1002/ame2.70200 ↗Kurz gefasst
Fachartikel in der Zeitschrift Animal Models and Experimental Medicine, online erschienen am 12.04.2026. Verfasst von Nusrat Jahan Moon und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Daffodil International University, Dhaka, Bangladesh. Hauptthemen laut MEDLINE: Plant Extracts, Analgesics, Anti-Inflammatory Agents, Fibrinolytic Agents. Die Arbeit nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Adenostemma lavenia, a plant long used in traditional medicine to manage pain, inflammation, and circulatory disorders, has not been thoroughly validated using modern scientific methods. This study presents the first comprehensive investigation into the analgesic, anti‐inflammatory, and thrombolytic potentials of the acetone extract of A. lavenia leaves (AEAL), employing an integrated strategy that combines in vivo, in vitro, and in silico methodologies.
Methods
The analgesic effects of the extract AEAL were evaluated in mice (five mice per group) using acetic acid‐induced writhing, formalin‐induced pain, and hot plate tests. Anti‐inflammatory activity was assessed through xylene‐induced ear edema in mice, heat‐induced hemolysis of human red blood cells (HRBC), and protein denaturation assays. In vitro clot lysis was performed in triplicate to determine the thrombolytic activity of AEAL and a standard streptokinase. Molecular docking, density functional theory (DFT), and ADME/T profiling were conducted to identify and evaluate potential bioactive compounds.
Results
AEAL demonstrated significant, dose‐dependent analgesic effects, reducing writhing responses by 53.74% (at 400 mg/kg), and inhibiting formalin‐induced pain by up to 65.76% ( p < 0.01). It also showed potent anti‐inflammatory activity, with edema inhibition of 55.17% at a 400 mg/kg dose ( p < 0.001), HRBC membrane stabilization (77.19%), and 85.96% suppression of protein denaturation. In thrombolytic testing, AEAL significantly ( p < 0.001) achieved 68.1% clot dissolution compared with the control group. In silico analysis revealed that sesquiphellandrene strongly bound to COX‐2 (−7.7 kcal/mol) and tissue plasminogen activator (tPA) (−6.9 kcal/mol), whereas derivatives of 2,3‐hexadienoic acid exhibited notable COX‐2 inhibition (−7.4 kcal/mol). ADMET predictions indicated favorable drug‐like properties. In the DFT analysis, sesquiphellandrene and 2,3‐hexadienoic acid, 2‐methyl‐4‐phenyl‐, methyl ester exhibited a narrow HOMO–LUMO energy gap, indicating high chemical reactivity and a greater propensity for electron‐transfer processes.
Conclusions
The AEAL exhibits robust analgesic, anti‐inflammatory, and thrombolytic activities, corroborated by computational analysis of its phytoconstituents. These results validate its ethnopharmacological use and highlight sesquiphellandrene as a promising candidate for future therapeutic development. Further isolation, mechanistic studies, and preclinical evaluation of sesquiphellandrene are warranted to harness its full pharmacological potential.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Daffodil International University, Dhaka, Bangladesh.
- Department of Chemistry, Chittagong University of Engineering & Technology, Chittagong, Bangladesh.
- Department of Pharmacy, Faculty of Biological Sciences, University of Chittagong, Chittagong, Bangladesh.
- Department of Pharmacy, University of Science and Technology Chittagong (USTC), Chittagong, Bangladesh.
ORCID-Profile: Mahathir Mohammad, Md Jahirul Islam Mamun, Nazmul Hasan Eshaque, Md Hossain Rasel, Zobayed Islam, Md Mahmudul Hasan, Md Liakot Ali, Md Tanvir Chowdhury, S M Moazzem Hossen
Zitieren
APA
Moon, N. J., Mohammad, M., Mamun, M. J. I., Nova, F. B. A., Eshaque, N. H., Rasel, M. H., Islam, Z., Hasan, M. M., Ali, M. L., Chowdhury, M. T., & Hossen, S. M. M. (2026). Pharmacological evaluation of Adenostemma lavenia acetone extract in Swiss Albino mice: Analgesic, anti‐inflammatory, and thrombolytic insights from in vivo, in vitro, density functional theory, and molecular docking studies. Animal Models and Experimental Medicine, 9(4), 765-784. https://doi.org/10.1002/ame2.70200
Vancouver
Moon NJ, Mohammad M, Mamun MJI, Nova FBA, Eshaque NH, Rasel MH, et al. Pharmacological evaluation of Adenostemma lavenia acetone extract in Swiss Albino mice: Analgesic, anti‐inflammatory, and thrombolytic insights from in vivo, in vitro, density functional theory, and molecular docking studies. Animal Models and Experimental Medicine. 2026;9(4):765-784. doi:10.1002/ame2.70200
BibTeX
@article{Moon2026,
author = {Moon, Nusrat Jahan and Mohammad, Mahathir and Mamun, Md Jahirul Islam and Nova, Fahmina Binty Azim and Eshaque, Nazmul Hasan and Rasel, Md Hossain and Islam, Zobayed and Hasan, Md Mahmudul and Ali, Md Liakot and Chowdhury, Md Tanvir and Hossen, S M Moazzem},
title = {Pharmacological evaluation of Adenostemma lavenia acetone extract in Swiss Albino mice: Analgesic, anti‐inflammatory, and thrombolytic insights from in vivo, in vitro, density functional theory, and molecular docking studies},
journal = {Animal Models and Experimental Medicine},
year = {2026},
volume = {9},
number = {4},
pages = {765--784},
doi = {10.1002/ame2.70200}
}
EUVIMED